The discoidin domain receptor 1 as a novel susceptibility gene for schizophrenia
Evidence suggests that myelin alterations could predispose to schizophrenia. Reduced expression of several myelin genes has been observed in schizophrenia patients. Recently, we identified the discoidin domain receptor 1 ( DDR1 ; located at human chromosome 6p21.3) as a myelin gene in the mouse mode...
Gespeichert in:
Veröffentlicht in: | Molecular psychiatry 2007-09, Vol.12 (9), p.833-841 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 841 |
---|---|
container_issue | 9 |
container_start_page | 833 |
container_title | Molecular psychiatry |
container_volume | 12 |
creator | Roig, B Virgos, C Franco, N Martorell, L Valero, J Costas, J Carracedo, A Labad, A Vilella, E |
description | Evidence suggests that myelin alterations could predispose to schizophrenia. Reduced expression of several myelin genes has been observed in schizophrenia patients. Recently, we identified the discoidin domain receptor 1 (
DDR1
; located at human chromosome 6p21.3) as a myelin gene in the mouse model and in a human oligodendroglial cell line. In the present study we screened for single nucleotide polymorphisms (SNPs) in the DNA from 100 schizophrenia patients. We identified a novel mutation within exon 10 that produces the amino-acid substitution N502S in the a–d isoforms, and M475V in the e isoform. However the frequency of the mutation (2%) was similar in schizophrenia patients and in control subjects. In a case–control assessment with 389 schizophrenic patients and 615 controls, we identified one SNP (SNP9, rs1049623) associated with schizophrenia (odds ratio=1.44, 95% confidence interval: 1.15–1.79, adjusted
P
=0.0016). This association was confirmed in haplotype analysis; the SNPs 9–10–11 (rs1049623, rs2267641 and rs2239518) haplotype remaining significant even after adjustment for multiple testing (adjusted
P
=0.0136). Of note was a strong gender dependence in the association, that is, statistical significance restricted to men (adjusted
P
-value=0.0002). Regression analysis of
DDR1
mRNA expression in peripheral blood lymphocytes from schizophrenia patients showed that the presence of the G allele significantly decreased the relative number of mRNA copies in a dose-dependent manner (
P
=0.003). These data suggest that the risk haplotype tags a
cis
-acting variant involved in the transcription regulation system of the gene. In conclusion, we propose the
DDR1
as a new susceptibility gene for schizophrenia. |
doi_str_mv | 10.1038/sj.mp.4001995 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_68229823</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A188803100</galeid><sourcerecordid>A188803100</sourcerecordid><originalsourceid>FETCH-LOGICAL-c574t-3fc048e12a39ab7d736adc97e486f478df4db0742fe8c41d49b190e76757a3453</originalsourceid><addsrcrecordid>eNqFks-L1TAQx4so7rp69KgURW99Jk3SJMdl8Rcs6GE9h7xk8l4ebVKTdmH9683jVYviIjlMmPnMd2aYqarnGG0wIuJdPmyGcUMRwlKyB9U5prxrGOPiYfkTJhuKBT2rnuR8KEwJssfVGeaUIkrYefX1Zg-19dlEb32obRx0MQkMjFNMNa51rnUd4i30dZ7z0e23vvfTXb2DALUrUDZ7_yOO-wTB66fVI6f7DM8We1F9-_D-5upTc_3l4-ery-vGME6nhjiDqADcaiL1lltOOm2N5EBF5ygX1lG7RZy2DoSh2FK5xRIB7zjjmlBGLqq3J90xxe8z5EkNZQroex0gzll1om2laMl_QSyFJFzKAr7-CzzEOYUyhGo7yjhrsRCFenUv1eKWYMzaVWqne1A-uDglbY511WUREYhghAq1-QdVnoXBmxjA-eL_I6E5JZgUc07g1Jj8oNOdwkgdr0HlgxpGtVxD4V8uvc7bAexKL-svwJsF0Nno3iUdjM8rJ6TsSCfWTnMJhR2kdej7Kr84JQQ9zQl-K_6K_wRXENLv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221231152</pqid></control><display><type>article</type><title>The discoidin domain receptor 1 as a novel susceptibility gene for schizophrenia</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Roig, B ; Virgos, C ; Franco, N ; Martorell, L ; Valero, J ; Costas, J ; Carracedo, A ; Labad, A ; Vilella, E</creator><creatorcontrib>Roig, B ; Virgos, C ; Franco, N ; Martorell, L ; Valero, J ; Costas, J ; Carracedo, A ; Labad, A ; Vilella, E</creatorcontrib><description>Evidence suggests that myelin alterations could predispose to schizophrenia. Reduced expression of several myelin genes has been observed in schizophrenia patients. Recently, we identified the discoidin domain receptor 1 (
DDR1
; located at human chromosome 6p21.3) as a myelin gene in the mouse model and in a human oligodendroglial cell line. In the present study we screened for single nucleotide polymorphisms (SNPs) in the DNA from 100 schizophrenia patients. We identified a novel mutation within exon 10 that produces the amino-acid substitution N502S in the a–d isoforms, and M475V in the e isoform. However the frequency of the mutation (2%) was similar in schizophrenia patients and in control subjects. In a case–control assessment with 389 schizophrenic patients and 615 controls, we identified one SNP (SNP9, rs1049623) associated with schizophrenia (odds ratio=1.44, 95% confidence interval: 1.15–1.79, adjusted
P
=0.0016). This association was confirmed in haplotype analysis; the SNPs 9–10–11 (rs1049623, rs2267641 and rs2239518) haplotype remaining significant even after adjustment for multiple testing (adjusted
P
=0.0136). Of note was a strong gender dependence in the association, that is, statistical significance restricted to men (adjusted
P
-value=0.0002). Regression analysis of
DDR1
mRNA expression in peripheral blood lymphocytes from schizophrenia patients showed that the presence of the G allele significantly decreased the relative number of mRNA copies in a dose-dependent manner (
P
=0.003). These data suggest that the risk haplotype tags a
cis
-acting variant involved in the transcription regulation system of the gene. In conclusion, we propose the
DDR1
as a new susceptibility gene for schizophrenia.</description><identifier>ISSN: 1359-4184</identifier><identifier>EISSN: 1476-5578</identifier><identifier>DOI: 10.1038/sj.mp.4001995</identifier><identifier>PMID: 17440435</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Adult ; Adult and adolescent clinical studies ; Aged ; Aged, 80 and over ; Amino acid substitution ; Asparagine - genetics ; Behavioral Sciences ; Biological and medical sciences ; Biological Psychology ; Chi-Square Distribution ; Chromosome 6 ; Discoidin Domain Receptor 1 ; DNA Mutational Analysis ; Exons - genetics ; Female ; Gene expression ; Gene Frequency ; Gene loci ; Gene regulation ; Genetic aspects ; Genetic Predisposition to Disease ; Genetic susceptibility ; Genomes ; Genotype ; Haplotypes ; Humans ; Isoforms ; Kinases ; Lymphocytes ; Male ; Medical sciences ; Medicine ; Medicine & Public Health ; Mental disorders ; Methionine - genetics ; Middle Aged ; Mutation ; Myelin ; Neurosciences ; original-article ; Peripheral blood ; Pharmacotherapy ; Polymorphism, Single Nucleotide ; Psychiatry ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychoses ; Receptor Protein-Tyrosine Kinases - genetics ; Regression Analysis ; Reverse Transcriptase Polymerase Chain Reaction - methods ; Risk factors ; Schizophrenia ; Schizophrenia - genetics ; Serine - genetics ; Single-nucleotide polymorphism ; Transcription ; Tumor necrosis factor-TNF ; Valine - genetics</subject><ispartof>Molecular psychiatry, 2007-09, Vol.12 (9), p.833-841</ispartof><rights>Springer Nature Limited 2007</rights><rights>2007 INIST-CNRS</rights><rights>COPYRIGHT 2007 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Sep 2007</rights><rights>Nature Publishing Group 2007.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c574t-3fc048e12a39ab7d736adc97e486f478df4db0742fe8c41d49b190e76757a3453</citedby><cites>FETCH-LOGICAL-c574t-3fc048e12a39ab7d736adc97e486f478df4db0742fe8c41d49b190e76757a3453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/sj.mp.4001995$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/sj.mp.4001995$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18996368$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17440435$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roig, B</creatorcontrib><creatorcontrib>Virgos, C</creatorcontrib><creatorcontrib>Franco, N</creatorcontrib><creatorcontrib>Martorell, L</creatorcontrib><creatorcontrib>Valero, J</creatorcontrib><creatorcontrib>Costas, J</creatorcontrib><creatorcontrib>Carracedo, A</creatorcontrib><creatorcontrib>Labad, A</creatorcontrib><creatorcontrib>Vilella, E</creatorcontrib><title>The discoidin domain receptor 1 as a novel susceptibility gene for schizophrenia</title><title>Molecular psychiatry</title><addtitle>Mol Psychiatry</addtitle><addtitle>Mol Psychiatry</addtitle><description>Evidence suggests that myelin alterations could predispose to schizophrenia. Reduced expression of several myelin genes has been observed in schizophrenia patients. Recently, we identified the discoidin domain receptor 1 (
DDR1
; located at human chromosome 6p21.3) as a myelin gene in the mouse model and in a human oligodendroglial cell line. In the present study we screened for single nucleotide polymorphisms (SNPs) in the DNA from 100 schizophrenia patients. We identified a novel mutation within exon 10 that produces the amino-acid substitution N502S in the a–d isoforms, and M475V in the e isoform. However the frequency of the mutation (2%) was similar in schizophrenia patients and in control subjects. In a case–control assessment with 389 schizophrenic patients and 615 controls, we identified one SNP (SNP9, rs1049623) associated with schizophrenia (odds ratio=1.44, 95% confidence interval: 1.15–1.79, adjusted
P
=0.0016). This association was confirmed in haplotype analysis; the SNPs 9–10–11 (rs1049623, rs2267641 and rs2239518) haplotype remaining significant even after adjustment for multiple testing (adjusted
P
=0.0136). Of note was a strong gender dependence in the association, that is, statistical significance restricted to men (adjusted
P
-value=0.0002). Regression analysis of
DDR1
mRNA expression in peripheral blood lymphocytes from schizophrenia patients showed that the presence of the G allele significantly decreased the relative number of mRNA copies in a dose-dependent manner (
P
=0.003). These data suggest that the risk haplotype tags a
cis
-acting variant involved in the transcription regulation system of the gene. In conclusion, we propose the
DDR1
as a new susceptibility gene for schizophrenia.</description><subject>Adult</subject><subject>Adult and adolescent clinical studies</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Amino acid substitution</subject><subject>Asparagine - genetics</subject><subject>Behavioral Sciences</subject><subject>Biological and medical sciences</subject><subject>Biological Psychology</subject><subject>Chi-Square Distribution</subject><subject>Chromosome 6</subject><subject>Discoidin Domain Receptor 1</subject><subject>DNA Mutational Analysis</subject><subject>Exons - genetics</subject><subject>Female</subject><subject>Gene expression</subject><subject>Gene Frequency</subject><subject>Gene loci</subject><subject>Gene regulation</subject><subject>Genetic aspects</subject><subject>Genetic Predisposition to Disease</subject><subject>Genetic susceptibility</subject><subject>Genomes</subject><subject>Genotype</subject><subject>Haplotypes</subject><subject>Humans</subject><subject>Isoforms</subject><subject>Kinases</subject><subject>Lymphocytes</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Mental disorders</subject><subject>Methionine - genetics</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Myelin</subject><subject>Neurosciences</subject><subject>original-article</subject><subject>Peripheral blood</subject><subject>Pharmacotherapy</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Psychiatry</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychoses</subject><subject>Receptor Protein-Tyrosine Kinases - genetics</subject><subject>Regression Analysis</subject><subject>Reverse Transcriptase Polymerase Chain Reaction - methods</subject><subject>Risk factors</subject><subject>Schizophrenia</subject><subject>Schizophrenia - genetics</subject><subject>Serine - genetics</subject><subject>Single-nucleotide polymorphism</subject><subject>Transcription</subject><subject>Tumor necrosis factor-TNF</subject><subject>Valine - genetics</subject><issn>1359-4184</issn><issn>1476-5578</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFks-L1TAQx4so7rp69KgURW99Jk3SJMdl8Rcs6GE9h7xk8l4ebVKTdmH9683jVYviIjlMmPnMd2aYqarnGG0wIuJdPmyGcUMRwlKyB9U5prxrGOPiYfkTJhuKBT2rnuR8KEwJssfVGeaUIkrYefX1Zg-19dlEb32obRx0MQkMjFNMNa51rnUd4i30dZ7z0e23vvfTXb2DALUrUDZ7_yOO-wTB66fVI6f7DM8We1F9-_D-5upTc_3l4-ery-vGME6nhjiDqADcaiL1lltOOm2N5EBF5ygX1lG7RZy2DoSh2FK5xRIB7zjjmlBGLqq3J90xxe8z5EkNZQroex0gzll1om2laMl_QSyFJFzKAr7-CzzEOYUyhGo7yjhrsRCFenUv1eKWYMzaVWqne1A-uDglbY511WUREYhghAq1-QdVnoXBmxjA-eL_I6E5JZgUc07g1Jj8oNOdwkgdr0HlgxpGtVxD4V8uvc7bAexKL-svwJsF0Nno3iUdjM8rJ6TsSCfWTnMJhR2kdej7Kr84JQQ9zQl-K_6K_wRXENLv</recordid><startdate>20070901</startdate><enddate>20070901</enddate><creator>Roig, B</creator><creator>Virgos, C</creator><creator>Franco, N</creator><creator>Martorell, L</creator><creator>Valero, J</creator><creator>Costas, J</creator><creator>Carracedo, A</creator><creator>Labad, A</creator><creator>Vilella, E</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20070901</creationdate><title>The discoidin domain receptor 1 as a novel susceptibility gene for schizophrenia</title><author>Roig, B ; Virgos, C ; Franco, N ; Martorell, L ; Valero, J ; Costas, J ; Carracedo, A ; Labad, A ; Vilella, E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c574t-3fc048e12a39ab7d736adc97e486f478df4db0742fe8c41d49b190e76757a3453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Adult and adolescent clinical studies</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Amino acid substitution</topic><topic>Asparagine - genetics</topic><topic>Behavioral Sciences</topic><topic>Biological and medical sciences</topic><topic>Biological Psychology</topic><topic>Chi-Square Distribution</topic><topic>Chromosome 6</topic><topic>Discoidin Domain Receptor 1</topic><topic>DNA Mutational Analysis</topic><topic>Exons - genetics</topic><topic>Female</topic><topic>Gene expression</topic><topic>Gene Frequency</topic><topic>Gene loci</topic><topic>Gene regulation</topic><topic>Genetic aspects</topic><topic>Genetic Predisposition to Disease</topic><topic>Genetic susceptibility</topic><topic>Genomes</topic><topic>Genotype</topic><topic>Haplotypes</topic><topic>Humans</topic><topic>Isoforms</topic><topic>Kinases</topic><topic>Lymphocytes</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Mental disorders</topic><topic>Methionine - genetics</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Myelin</topic><topic>Neurosciences</topic><topic>original-article</topic><topic>Peripheral blood</topic><topic>Pharmacotherapy</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Psychiatry</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychoses</topic><topic>Receptor Protein-Tyrosine Kinases - genetics</topic><topic>Regression Analysis</topic><topic>Reverse Transcriptase Polymerase Chain Reaction - methods</topic><topic>Risk factors</topic><topic>Schizophrenia</topic><topic>Schizophrenia - genetics</topic><topic>Serine - genetics</topic><topic>Single-nucleotide polymorphism</topic><topic>Transcription</topic><topic>Tumor necrosis factor-TNF</topic><topic>Valine - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roig, B</creatorcontrib><creatorcontrib>Virgos, C</creatorcontrib><creatorcontrib>Franco, N</creatorcontrib><creatorcontrib>Martorell, L</creatorcontrib><creatorcontrib>Valero, J</creatorcontrib><creatorcontrib>Costas, J</creatorcontrib><creatorcontrib>Carracedo, A</creatorcontrib><creatorcontrib>Labad, A</creatorcontrib><creatorcontrib>Vilella, E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roig, B</au><au>Virgos, C</au><au>Franco, N</au><au>Martorell, L</au><au>Valero, J</au><au>Costas, J</au><au>Carracedo, A</au><au>Labad, A</au><au>Vilella, E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The discoidin domain receptor 1 as a novel susceptibility gene for schizophrenia</atitle><jtitle>Molecular psychiatry</jtitle><stitle>Mol Psychiatry</stitle><addtitle>Mol Psychiatry</addtitle><date>2007-09-01</date><risdate>2007</risdate><volume>12</volume><issue>9</issue><spage>833</spage><epage>841</epage><pages>833-841</pages><issn>1359-4184</issn><eissn>1476-5578</eissn><abstract>Evidence suggests that myelin alterations could predispose to schizophrenia. Reduced expression of several myelin genes has been observed in schizophrenia patients. Recently, we identified the discoidin domain receptor 1 (
DDR1
; located at human chromosome 6p21.3) as a myelin gene in the mouse model and in a human oligodendroglial cell line. In the present study we screened for single nucleotide polymorphisms (SNPs) in the DNA from 100 schizophrenia patients. We identified a novel mutation within exon 10 that produces the amino-acid substitution N502S in the a–d isoforms, and M475V in the e isoform. However the frequency of the mutation (2%) was similar in schizophrenia patients and in control subjects. In a case–control assessment with 389 schizophrenic patients and 615 controls, we identified one SNP (SNP9, rs1049623) associated with schizophrenia (odds ratio=1.44, 95% confidence interval: 1.15–1.79, adjusted
P
=0.0016). This association was confirmed in haplotype analysis; the SNPs 9–10–11 (rs1049623, rs2267641 and rs2239518) haplotype remaining significant even after adjustment for multiple testing (adjusted
P
=0.0136). Of note was a strong gender dependence in the association, that is, statistical significance restricted to men (adjusted
P
-value=0.0002). Regression analysis of
DDR1
mRNA expression in peripheral blood lymphocytes from schizophrenia patients showed that the presence of the G allele significantly decreased the relative number of mRNA copies in a dose-dependent manner (
P
=0.003). These data suggest that the risk haplotype tags a
cis
-acting variant involved in the transcription regulation system of the gene. In conclusion, we propose the
DDR1
as a new susceptibility gene for schizophrenia.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>17440435</pmid><doi>10.1038/sj.mp.4001995</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1359-4184 |
ispartof | Molecular psychiatry, 2007-09, Vol.12 (9), p.833-841 |
issn | 1359-4184 1476-5578 |
language | eng |
recordid | cdi_proquest_miscellaneous_68229823 |
source | MEDLINE; SpringerNature Journals |
subjects | Adult Adult and adolescent clinical studies Aged Aged, 80 and over Amino acid substitution Asparagine - genetics Behavioral Sciences Biological and medical sciences Biological Psychology Chi-Square Distribution Chromosome 6 Discoidin Domain Receptor 1 DNA Mutational Analysis Exons - genetics Female Gene expression Gene Frequency Gene loci Gene regulation Genetic aspects Genetic Predisposition to Disease Genetic susceptibility Genomes Genotype Haplotypes Humans Isoforms Kinases Lymphocytes Male Medical sciences Medicine Medicine & Public Health Mental disorders Methionine - genetics Middle Aged Mutation Myelin Neurosciences original-article Peripheral blood Pharmacotherapy Polymorphism, Single Nucleotide Psychiatry Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychoses Receptor Protein-Tyrosine Kinases - genetics Regression Analysis Reverse Transcriptase Polymerase Chain Reaction - methods Risk factors Schizophrenia Schizophrenia - genetics Serine - genetics Single-nucleotide polymorphism Transcription Tumor necrosis factor-TNF Valine - genetics |
title | The discoidin domain receptor 1 as a novel susceptibility gene for schizophrenia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T23%3A06%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20discoidin%20domain%20receptor%201%20as%20a%20novel%20susceptibility%20gene%20for%20schizophrenia&rft.jtitle=Molecular%20psychiatry&rft.au=Roig,%20B&rft.date=2007-09-01&rft.volume=12&rft.issue=9&rft.spage=833&rft.epage=841&rft.pages=833-841&rft.issn=1359-4184&rft.eissn=1476-5578&rft_id=info:doi/10.1038/sj.mp.4001995&rft_dat=%3Cgale_proqu%3EA188803100%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=221231152&rft_id=info:pmid/17440435&rft_galeid=A188803100&rfr_iscdi=true |